123
Participants
Start Date
August 31, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Placebo
Infusion of placebo, same infusion rates as for arm 2
ICI35,868 (propofol)
Infusion of propofol: initiation with 0.17 mg/kg for 3 minutes followed by maintenance with 25 µg/kg/minute
ICI35,868 (propofol)
Infusion of propofol: initiation with 0.33 mg/kg for 3 minutes followed by maintenance with 50 µg/kg/minute
ICI35,868 (propofol)
Infusion of propofol: initiation with 0.5 mg/kg for 3 minutes followed by maintenance with 75 µg/kg/minute
ICI35,868 (propofol)
Infusion of propofol: initiation with 0.8 mg/kg for 3 minutes followed by maintenance with 120 µg/kg/minute
ICI35,868 (propofol)
Infusion of propofol: initiation with 0.5 mg/kg for 1 minutes followed by maintenance with 75 µg/kg/minute
ICI35,868 (propofol)
Infusion of propofol: initiation with 0.5 mg/kg for 5 minutes followed by maintenance with 75 µg/kg/minute
Research Site, Isesaki
Research Site, Moriya
Lead Sponsor
Johnson & Johnson K.K. Medical Company
INDUSTRY
AstraZeneca
INDUSTRY